Intracerebroventricular or stereotaxic striatal injection of exogenous IL-1β exacerbated stroke-induced damage in young animals [80], and conversely, injury was reduced after the IL-1β antagonist, IL-1ra, was injected either locally into the striatum [81] or into an intracerebral ventricle [82]. Here, IL1B is linked to stroke disorder.